Morse Barnes Brown and Pendleton
Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Thursday, October 29, 2009

Virdante Pharmaceuticals boosts first round to $47M

By Mass High Tech staff

Cambridge-based Virdante Pharmaceuticals Inc. reports it has raised new funding to bring its Series A round to $47.75 million, to continue development of antibody-based drugs that have better anti-inflammatory activity, to better treat autoimmune and inflammatory disorders.

The new round was led by Thomas, McNerney & Partners with participation by Osage Partners, along with previous investors Clarus Ventures, Venrock, MedImmune Ventures and Biogen Idec New Ventures. Virdante, which was called Centaurus Pharmaceuticals until April 2008, leases office and lab space in the same building as the Biogen Idec Innovation Incubator.

Virdante has received $30 million of the Series A funding, according to CEO John Ripple, and the remainder of the committed funds are based on the company achieving certain corporate milestones. The funds are sepicfically targeted to the launch of Virdante’s second development effort, called sFC, a synthetic fragment of an antibody which is based on the sugar molecule that carries the anti-inflammatory effect in the antibody.

Ripple says that he is continuing the company’s conservative growth plan, but does anticipate adding staff going forward.

“We will be making a few selective hires from now through 2010,” Ripple said.

Virdante has licensed technology from Rockefeller University in New York City, where the startup’s scientific founder, Jeffrey Ravetch, is a professor. Ravetch is an expert on immunoglobulin antibodies, found to reduce inflammation caused by such disorders as arthritis and asthma.

Eric Aguiar, a partner at Thomas, McNerney & Partners, has joined the Virdante board of directors. Aguiar says that Virdante’s technology is aimed at the $4 billion market for plasma-derived products.
 

 

 

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Comments

Please Login/Register to post comments.

No comments have been added or approved.

On the MHT blog now

Flagsuit wins another NASA Astronaut Glove Challenge

Southwest Harbor, Maine's Peter Homer won $450,000 in NASA's Astronaut Glove Challenge yesterday. This is Homer's second time winning the contest. Homer's first win in 2007 launched his startup, Flagsuit. Flagsuit is developing pressure suits using the same technology as Homer's prizewinning gloves -- for use as a wearable substitute for hyperbaric chambers used to treat conditions such as ...

Read More

Most Popular Stories
EmailedViewed
Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
FinanceFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of, registration on, this site constitutes acceptance of our User Agreement. Please read our Privacy Policy (updated) A publishing partner with Portfolio